WuXi AppTec Co., Ltd. (SHA:603259)

Market Cap	195.46B
Revenue (ttm)	37.92B
Net Income (ttm)	9.45B
Shares Out	2.89B
EPS (ttm)	2.73
PE Ratio	20.86
Forward PE	17.20
Dividend	0.98 (1.49%)
Ex-Dividend Date	Jun 26, 2024

Volume	36,547,707
Average Volume	37,220,148
Open	65.50
Previous Close	65.74
Day's Range	65.39 - 68.12
52-Week Range	36.36 - 70.68
Beta	0.89
RSI	61.41
Earnings Date	Mar 18, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603259

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.